These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 34283274)
1. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway. Janthamala S; Jusakul A; Kongpetch S; Kimawaha P; Klanrit P; Loilome W; Namwat N; Techasen A Naunyn Schmiedebergs Arch Pharmacol; 2021 Oct; 394(10):2049-2059. PubMed ID: 34283274 [TBL] [Abstract][Full Text] [Related]
2. Arctigenin inhibits the progression of colorectal cancer through epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway. Chen XF; Liu PG; Sheng N; Li XS; Hu RK; Zhu LX; Feng P PLoS One; 2024; 19(9):e0308947. PubMed ID: 39331595 [TBL] [Abstract][Full Text] [Related]
3. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis. Techasen A; Loilome W; Namwat N; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P Tumour Biol; 2014 Sep; 35(9):8645-52. PubMed ID: 24867095 [TBL] [Abstract][Full Text] [Related]
4. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma. Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439 [TBL] [Abstract][Full Text] [Related]
5. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents. Srijiwangsa P; Ponnikorn S; Na-Bangchang K BMC Pharmacol Toxicol; 2018 Jun; 19(1):32. PubMed ID: 29914576 [TBL] [Abstract][Full Text] [Related]
7. Sulfated galactans from the red seaweed Gracilaria fisheri exerts anti-migration effect on cholangiocarcinoma cells. Sae-Lao T; Luplertlop N; Janvilisri T; Tohtong R; Bates DO; Wongprasert K Phytomedicine; 2017 Dec; 36():59-67. PubMed ID: 29157829 [TBL] [Abstract][Full Text] [Related]
8. Arctigenin promotes apoptosis in ovarian cancer cells via the iNOS/NO/STAT3/survivin signalling. Huang K; Li LA; Meng YG; You YQ; Fu XY; Song L Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):507-11. PubMed ID: 24842412 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells. Thongchot S; Ferraresi A; Vidoni C; Loilome W; Yongvanit P; Namwat N; Isidoro C Cancer Lett; 2018 Aug; 430():160-171. PubMed ID: 29802929 [TBL] [Abstract][Full Text] [Related]
10. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy. Yothaisong S; Dokduang H; Techasen A; Namwat N; Yongvanit P; Bhudhisawasdi V; Puapairoj A; Riggins GJ; Loilome W Tumour Biol; 2013 Dec; 34(6):3637-48. PubMed ID: 23832540 [TBL] [Abstract][Full Text] [Related]
12. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma. Chen H; Zhu B; Zhao L; Liu Y; Zhao F; Feng J; Jin Y; Sun J; Geng R; Wei Y Cell Physiol Biochem; 2018; 47(2):641-653. PubMed ID: 29794468 [TBL] [Abstract][Full Text] [Related]
13. BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma. Duangkumpha K; Techasen A; Loilome W; Namwat N; Thanan R; Khuntikeo N; Yongvanit P Tumour Biol; 2014 Oct; 35(10):9667-76. PubMed ID: 24969562 [TBL] [Abstract][Full Text] [Related]
14. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells. Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray. Nitta T; Mitsuhashi T; Hatanaka Y; Miyamoto M; Oba K; Tsuchikawa T; Suzuki Y; Hatanaka KC; Hirano S; Matsuno Y Br J Cancer; 2014 Sep; 111(7):1363-72. PubMed ID: 25077440 [TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA NEAT1 Promotes Growth and Metastasis of Cholangiocarcinoma Cells. Zhang C; Li JY; Tian FZ; Zhao G; Hu H; Ma YF; Yang YL Oncol Res; 2018 Jul; 26(6):879-888. PubMed ID: 28810932 [TBL] [Abstract][Full Text] [Related]
17. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway. Zhao W; Yang S; Chen J; Zhao J; Dong J Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944 [TBL] [Abstract][Full Text] [Related]
18. Atractylodin inhibited the migration and induced autophagy in cholangiocarcinoma cells via PI3K/AKT/mTOR and p38MAPK signalling pathways. Acharya B; Chaijaroenkul W; Na-Bangchang K J Pharm Pharmacol; 2021 Aug; 73(9):1191-1200. PubMed ID: 33885818 [TBL] [Abstract][Full Text] [Related]
19. Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo. Trakoonsenathong R; Kunprom W; Aphivatanasiri C; Yueangchantuek P; Pimkeeree P; Sorin S; Khawkhiaw K; Chiu CF; Okada S; Wongkham S; Saengboonmee C Sci Rep; 2024 Jun; 14(1):13726. PubMed ID: 38877189 [TBL] [Abstract][Full Text] [Related]
20. Anti-cancer activity of asiatic acid against human cholangiocarcinoma cells through inhibition of proliferation and induction of apoptosis. Sakonsinsiri C; Kaewlert W; Armartmuntree N; Thanan R; Pakdeechote P Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):28-33. PubMed ID: 30084792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]